Showing results (281-290 of 554) with videos related to

Sort By:
Pageof 56
BJU International|July 23, 2011
The natural history of metastatic progression in men with prostate-specific antigen recurrence after radical prostatectomy: long-term follow-upEmmanuel S Antonarakis, Zhaoyong Feng, Bruce J Trock, et al.
Translational Andrology and Urology|October 22, 2024
Ferroptosis-related gene signature predicts prognosis and immune microenvironment in prostate cancerHao Wang, Dalang Fang, Jinxin Zhu, et al.
The Prostate|December 23, 2015
Prognostic factors for clinical outcomes in patients with metastatic castration resistant prostate cancer treated with sequential novel androgen receptor-directed therapiesRosa Nadal, Hua-Ling Tsai, Victoria J Sinibaldi, et al.
American Journal of Medical Genetics|March 15, 1994
Follow-up of a report of a potential linkage for schizophrenia on chromosome 22q12-q13.1: Part 2A E Pulver, M Karayiorgou, V K Lasseter, et al.
Prostate Cancer|January 7, 2026
Cellular Immunotherapy for Prostate Cancer: Lessons Learned From 15 Years of Sipuleucel-TNeal D Shore, Emmanuel S Antonarakis, Jason Hafron, et al.
Prostate Cancer and Prostatic Diseases|July 11, 2018
Compositional differences in gastrointestinal microbiota in prostate cancer patients treated with androgen axis-targeted therapiesKaren S Sfanos, Mark C Markowski, Lauren B Peiffer, et al.
American Journal of Medical Genetics|March 15, 1994
Sequential strategy to identify a susceptibility gene for schizophrenia: report of potential linkage on chromosome 22q12-q13.1: Part 1A E Pulver, M Karayiorgou, P S Wolyniec, et al.
The Prostate|September 2, 2014
Clinical activity of enzalutamide in Docetaxel-naïve and Docetaxel-pretreated patients with metastatic castration-resistant prostate cancerRosa Nadal, Zhe Zhang, Hibba Rahman, et al.
Frontiers in Oncology|June 27, 2025
Case Report: Metastatic small bowel adenocarcinoma with DNA mismatch repair deficiency in an organ transplant recipient treated with anti-PD-1 immunotherapyQuan H Phung, Alexander K Tsai, Byoung U Park, et al.
Prostate Cancer and Prostatic Diseases|October 9, 2013
The effect of the frequency and duration of PSA measurement on PSA doubling time calculations in men with biochemically recurrent prostate cancerC J Paller, D Olatoye, S Xie, et al.
Pageof 56